Time for a Change? Looking Ahead at New Treatment Strategies for the Management of Dyslipidemia
This Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.
This activity is supported by an educational grant from Merck Sharp & Dohme Corp.
Patrick Curtin PharmD, BCPS
Overlook Medical Center
Summit, New Jersey
After completing this continuing education program, the participant will be able to:
- Examine the changes to previous guidelines as presented in the 2013 American Heart Association/ American College of Cardiology lipid guidelines.
- Determine the use of the pooled cohort equations for the assessment of patients’ 10-year atherosclerotic cardiovascular risk.
- Identify available and investigational medications and treatment strategies to develop patient-specific management of dyslipidemia.
Type of activity:
July 6, 2015
July 6, 2017
Estimated time to complete activity
: 2.0 hours
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-068-H01-P. The activity is available for CE credit through July 6, 2017.